Insider · CIK 0001328507

KARR ROBERT W

Reports to the SEC for 2 companies · MEMPHIS, TN

sec.gov

Transactions

Companies

Filings

CIK

0001328507

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-09-16	Aceragen, Inc.P Purchase	Director	PPurchase	+5,750 sh	$1.76	+$10.1K	6,299
2013-08-16	Aceragen, Inc.Stock OptionA Award	Director	AAward	+40K sh	—	—	40,000
2013-07-26	Aceragen, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2012-06-12	Aceragen, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2011-06-14	Aceragen, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2010-06-15	Aceragen, Inc.Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2010-04-30	Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	$3.28	+$32.8K	10,000
2009-06-16	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2009-05-07	Oncternal Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	$9.53	+$95.3K	10,000
2008-12-31	Oncternal Therapeutics, Inc.A Award	Director	AAward	+89.07 sh	$16.84	+$1,499.939	5,224.32
2008-01-02	Aceragen, Inc.Stock OptionA Award	Director	AAward	+45K sh	—	—	45,000
2008-01-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+348.43 sh	$14.35	+$4,999.971	3,889.68
2007-12-31	Oncternal Therapeutics, Inc.A Award	Director	AAward	+156.79 sh	$14.35	+$2,249.937	3,541.25
2007-10-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+307.13 sh	$16.28	+$5,000.076	3,384.46
2007-09-30	Oncternal Therapeutics, Inc.A Award	Director	AAward	+138.21 sh	$16.28	+$2,250.059	3,077.33
2007-07-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+308.83 sh	$16.19	+$4,999.958	2,939.12
2007-01-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+280.27 sh	$17.84	+$5,000.017	1,385.19
2006-10-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+270.56 sh	$9.24	+$2,499.974	1,104.92
2006-07-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+274.73 sh	$9.10	+$2,500.043	834.36
2006-04-27	Oncternal Therapeutics, Inc.Directors Stock Option (Right to Buy)A Award	Director	AAward	+7,334 sh	$10.08	+$73.9K	7,334
2006-04-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+228.94 sh	$10.92	+$2,500.025	559.63
2006-01-01	Oncternal Therapeutics, Inc.A Award	Director	AAward	+330.69 sh	$7.56	+$2,500.016	330.69
2005-10-03	Aceragen, Inc.P Purchase	Director	PPurchase	+4,390 sh	$0.57	+$2,500.105	4,390
2005-07-01	Aceragen, Inc.Stock OptionsA Award	Director	AAward	+10K sh	—	—	10,000
2005-06-15	Aceragen, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Sep 184
IDERA PHARMACEUTICALS, INC.0001209191-13-044741
SEC(opens sec.gov)
Aug 164
IDERA PHARMACEUTICALS, INC.0001209191-13-041241
SEC(opens sec.gov)
Jul 304
IDERA PHARMACEUTICALS, INC.0001209191-13-038391
SEC(opens sec.gov)
Jun 124
KARR ROBERT W0001209191-12-033570
SEC(opens sec.gov)
Jun 144
KARR ROBERT W0001209191-11-034638
SEC(opens sec.gov)
Jun 154
KARR ROBERT W0001209191-10-034312
SEC(opens sec.gov)
May 44
KARR ROBERT W0001209191-10-025085
SEC(opens sec.gov)
Jun 164
KARR ROBERT W0001209191-09-032520
SEC(opens sec.gov)
May 114
KARR ROBERT W0001209191-09-025795
SEC(opens sec.gov)
Jan 54
Karr Robert W0001209191-09-001183
SEC(opens sec.gov)
Jan 44
IDERA PHARMACEUTICALS, INC.0001209191-08-001674
SEC(opens sec.gov)
Jan 24
GTX INC /DE/0001209191-08-000407
SEC(opens sec.gov)
Oct 24
GTX INC /DE/0001209191-07-055935
SEC(opens sec.gov)
Jul 24
GTX INC /DE/0001209191-07-040058
SEC(opens sec.gov)
Jan 34
GTX INC /DE/0001209191-07-000388
SEC(opens sec.gov)
Oct 44
GTX INC /DE/0001209191-06-053549
SEC(opens sec.gov)
Jul 54
GTX INC /DE/0001209191-06-039815
SEC(opens sec.gov)
May 44/A
Karr Robert W0001209191-06-027649
SEC(opens sec.gov)

Companies

Address

175 TOYOTA PLAZA 7TH FLOOR

MEMPHIS, TN, 38103